LONDON (Bloomberg): Singapore health officials have recalled three of 46 versions of the diabetes drug metformin after finding amounts of a cancer-causing substance that was "above the acceptable level".
The recalled drugs had been sold locally for only a short time, and the risk to patients who had taken them is low, Singapore's Health Sciences Authority said in a statement.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
